We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Astellas and Medivation Announce Initiation of Phase 2 Clinical Trial of MDV3100 in Hormone-Naive Prostate Cancer Patients

Product News   May 10, 2011

 
Astellas and Medivation Announce Initiation of Phase 2 Clinical Trial of MDV3100 in Hormone-Naive Prostate Cancer Patients
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Largest Study in Single-Cell Genomics Reveals Heterogeneity Link to Cancer Relapse Using Mission Bio Tapestri® Platform

Product News

The study findings to be presented by MD Anderson Cancer Center at 60th Annual Hematology Meeting in San Diego, CA.

READ MORE

Metrohm USA Contributes to Global Monograph Modernization Initiative

Product News

Metrohm's collaboration with the United States Pharmacopeia will concentrate on the pharmaceutical industry.

READ MORE

Certara Launches Trial Simulator 2.3 to Improve Clinical Trial Success

Product News

Certara’s clinical trial simulator enables drug developers to test ideas and
evaluate relevant and effective trials for every phase of clinical drug development.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE